13F filing recap · Q2 2022

What did Patient Capital Management buy in Q2 2022?

Reported stock-position changes between this filing and the previous one.

Stock value

$203.97M

Positions

Estimated turnover

37.4%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

EXPEExpedia Group, Inc.$8.73Mreported value+92.1K shares UALUnited Airlines Holdings, Inc.$4.91Mreported value+138.5K shares LEN.BLennar Corp /new/$734.0Kreported value+12.5K shares UCOProshares Trust II$419.0Kreported value+10.0K shares

Increased positions

BABAAlibaba Group Holding Limited$14.12Mreported value+21.4K shares+20.8%MATMattel Inc /de/$10.43Mreported value+40.0K shares+9.4%TEVATeva Pharmaceutical Industries Limited$8.97Mreported value+192.1K shares+19.2%OMFOnemain Holdings, Inc.$8.39Mreported value+66.7K shares

Reduced positions

OVVOvintiv Inc.$11.58Mreported value-4.2K shares-1.6%DXCDxc Technology Co$8.23Mreported value-30.0K shares-9.9%DALDelta Air Lines, Inc.$5.95Mreported value-42.7K shares-17.2%NCLHNorwegian Cruise Line Holdings Ltd.$5.06Mreported value-35.9K shares

Exited positions

TVTYTivity Health Inc.$8.09Mprior reported value-251.6K shares-100.0%HLFHerbalife Ltd.$5.90Mprior reported value-194.3K shares-100.0%TUPTupperware Brands Corp$5.84Mprior reported value-300.3K shares-100.0%PTONPeloton Interactive, Inc.$3.87Mprior reported value-146.3K shares